The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 26, 2023

Filed:

Jul. 01, 2021
Applicant:

Kappa-pharma Llc, Alachua, FL (US);

Inventors:

Georgiy Nikonov, Gainesville, FL (US);

Levon Isakulyan, New York, NY (US);

Michael Voronkov, Chelsea, MA (US);

Assignee:

Kappa-Pharma LLC, Alachua, FL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); C07D 489/02 (2006.01); C07C 229/38 (2006.01); A61P 25/36 (2006.01); C07D 221/28 (2006.01);
U.S. Cl.
CPC ...
C07D 489/02 (2013.01); A61P 25/36 (2018.01); C07C 229/38 (2013.01); C07D 221/28 (2013.01); A61K 9/0053 (2013.01);
Abstract

The present invention relates to opiate derived compositions and their antagonists useful in therapeutic areas associated with opioid receptor modulation. A 3-hexadienoate modification of the opioids is formulated to improve opiates' engagement of the opioid receptors when given orally. A 3-hexadienoate modification of nalbuphine or a pharmaceutically acceptable salt of thereof to improve quality of pain management when given intravenously, intranasally, transdermally, sublingually, rectally, topically, intramuscularly, subcutaneously or via inhalation. A 3-hexadienoate modification of the opioids antagonists is formulated to improve inhibition of the opioid receptors when given orally. A 3-hexadienoate modification of naloxone or a pharmaceutically acceptable salt of thereof to improve quality of Sobering when given intravenously, intranasally, transdermally, sublingually, rectally, topically, intramuscularly, subcutaneously or via inhalation.


Find Patent Forward Citations

Loading…